This inventor holds 1 USPTO granted patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Medshine Discovery Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Guoqing Li: Innovator in Pharmaceutical Science
Introduction
Guoqing Li is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of caspase inhibitors. His work has the potential to impact the treatment of various caspase-related diseases.
Latest Patents
Guoqing Li holds 1 patent for a caspase inhibitor and pharmaceutical composition, which includes a therapeutic method for its use. The patent discloses a class of compounds that serve as caspase inhibitors, specifically focusing on a compound represented in formula (I) or its pharmaceutically acceptable salts. This innovation is crucial for advancing treatment options for diseases associated with caspase activity.
Career Highlights
Throughout his career, Guoqing Li has worked with notable companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Medshine Discovery Inc. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.
Collaborations
Guoqing Li has collaborated with esteemed colleagues, including Haiying He and Songliang Wu. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Guoqing Li's contributions to pharmaceutical science, particularly through his patent on caspase inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic methods in treating caspase-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile